What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in menopause?

The Cardio Risk Check (Herz-Kreislauf Risiko-Test) is marketed as a tool to assess cardiovascular risk, including during menopause. Menopause increases cardiovascular risk due to declining estrogen, affecting blood pressure, lipids, and vascular function. Such a test may include genetic variants (e.g., for hypertension or lipid metabolism) and biomarkers like cholesterol or CRP. However, evidence for a specific role in menopause is limited: most risk factors are lifestyle- and hormone-driven, and single-gene effects are small. The test can provide general guidance but does not replace clinical risk scores (e.g., SCORE2 or Framingham). Women in menopause should discuss results with a clinician and not rely solely on genetic data. Caveat: DTC tests often overclaim single-SNP predictive power. Evidence: mixed.